Vaxart Inc (VXRT)
0.6584
-0.05
(-7.23%)
USD |
NASDAQ |
Apr 25, 16:00
0.7067
+0.05
(+7.34%)
After-Hours: 20:00
Vaxart Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 2.454M |
June 30, 2019 | 2.842M |
March 31, 2019 | 3.229M |
December 31, 2018 | 3.611M |
September 30, 2018 | 4.09M |
June 30, 2018 | 4.516M |
March 31, 2018 | 4.95M |
December 31, 2017 | 0.30M |
Date | Value |
---|---|
September 30, 2017 | 0.30M |
June 30, 2017 | 0.30M |
March 31, 2017 | 0.40M |
December 31, 2016 | 0.50M |
September 30, 2016 | 0.70M |
June 30, 2016 | 0.70M |
March 31, 2016 | 0.80M |
December 31, 2015 | 0.90M |
September 30, 2015 | 0.90M |
June 30, 2015 | 1.00M |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
2.842M
Maximum
Jun 2019
0.2787M
Average
--
Median
Dec 2019
Total Long Term Debt (Quarterly) Benchmarks
Novavax Inc | 168.02M |
aTyr Pharma Inc | -- |
Allogene Therapeutics Inc | 0.00 |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 20.25M |